Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
IPSC.mesodermal_primed: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,329 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Basal metabolic rate | METBL000007 | 146.20 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 2 | Trunk mass | BCOMP000019 | 144.13 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 3 | Arm mass | BCOMP000014 | 143.84 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 4 | Body water mass | BCOMP000006 | 138.32 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 5 | Whole body impedance | BCOMP000007 | 131.54 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 6 | Fat-free mass | BCOMP000008 | 125.21 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 7 | KIAA0040 levels | PROLV001136 | 117.03 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 8 | Arm impedance | BCOMP000013 | 97.17 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 9 | Leg mass | BCOMP000017 | 96.90 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 10 | Peak expiratory flow | RESPI000023 | 89.30 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 11 | Hand grip strength | MSKEL000030 | 80.57 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 12 | Physical function | MISCL000041 | 78.60 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 13 | Body size, adult | BMORP000003 | 75.94 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 14 | Leg impedance | BCOMP000016 | 75.13 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 15 | Leg fat percentage | BCOMP000015 | 71.15 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 16 | Medication, laxative | GASTR000016 | 65.42 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 17 | Lean mass | BCOMP000009 | 63.35 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 18 | Brainstem volume | NIMAG000017 | 61.08 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 19 | Luteinizing hormone | ENDOC000008 | 59.98 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 20 | Pregnancy complication, vomiting | REPRO000035 | 58.44 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 21 | Venous insufficiency | VASCU000065 | 57.99 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 22 | Household income | SOCIO000026 | 57.60 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 23 | Medication, heart failure | CARDI000044 | 57.59 | Cardiac | Hepatocyte | 0 | 3 | 6 | 20 | |
| 24 | IL13RA1 levels | PROLV001047 | 54.31 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 25 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 51.38 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 26 | Height | BMORP000009 | 51.19 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 27 | ASGR1/DCBLD2 ratio | PRORT000147 | 47.71 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 28 | Respiratory symptom | RESPI000032 | 46.03 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 29 | Spread preference | DTSUP000018 | 45.86 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 30 | ACTA2 levels | PROLV000017 | 43.49 | Protein levels | Myeloid | 1 | 1 | 4 | 7 | |
| 31 | Weight | BMORP000015 | 42.87 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 32 | CD177 levels | PROLV000314 | 42.85 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 33 | Pain, generic | MSKEL000035 | 42.42 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 34 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 41.40 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 35 | Vehicle ownership | SOCIO000015 | 41.22 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 36 | MST1 levels | PROLV001344 | 40.09 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 37 | BACH1/HEXIM1 ratio | PRORT000195 | 39.99 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 16 | |
| 38 | Sexually transmitted infection | IMMUN000072 | 39.84 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 39 | Medication, antimigraine | NEURO000011 | 39.66 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 40 | GFRA3/LAYN ratio | PRORT001211 | 38.62 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 41 | Social and economic stability | SOCIO000028 | 38.52 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 42 | FEV1/FVC ratio | RESPI000021 | 38.17 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 43 | Hearing loss, age-related | AUDIO000006 | 37.80 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 44 | Abdominal and pelvic pain | GASTR000043 | 37.23 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 45 | Snoring | RESPI000036 | 37.03 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 46 | Exercise workload | CARDI000024 | 36.79 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 47 | ASGR1/GGT5 ratio | PRORT000148 | 36.73 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 48 | Loose teeth | DENTA000012 | 36.55 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 49 | Heart failure, congestive | CARDI000004 | 35.64 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 50 | Hip circumference, adjusted for BMI | BMORP000005 | 34.87 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 51 | Benign prostatic hyperplasia | REPRO000011 | 34.46 | Reproductive | Respiratory epithelium | 25 | 0 | 5 | 7 | |
| 52 | PON1 levels | PROLV001600 | 33.98 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 53 | DAB2/TBL1X ratio | PRORT000841 | 33.81 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 54 | Medication use, pain etc, none | MISCL000032 | 32.91 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 55 | RNF146 levels | PROLV001744 | 32.79 | Protein levels | Muscle / cardiac | 0 | 1 | 3 | 18 | |
| 56 | Cerebellar volume | NIMAG000019 | 32.47 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 57 | ROBO1/SPON1 ratio | PRORT001744 | 32.36 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 58 | HEXIM1/IKBKG ratio | PRORT001276 | 32.35 | Protein ratios | Vascular | 0 | 0 | 8 | 20 | |
| 59 | Bowel function | GASTR000002 | 31.94 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 60 | Weight, birth | BMORP000018 | 31.81 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 61 | Cognitive function | PSYCH000002 | 30.85 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 62 | GLB1/PCSK9 ratio | PRORT001217 | 30.77 | Protein ratios | Hepatocyte | 90 | 3 | 15 | 19 | |
| 63 | CA1/HMBS ratio | PRORT000269 | 30.74 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 64 | IFIT3 levels | PROLV001017 | 30.64 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 65 | Thigh muscle volume | BMORP000020 | 30.36 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 66 | Abnormal lung findings | RESPI000026 | 30.31 | Respiratory | Hepatocyte | 1 | 2 | 7 | 19 | |
| 67 | Family history, chronic lung disease | RESPI000002 | 30.17 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 68 | Trunk fat percentage | BCOMP000018 | 29.83 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 69 | Pain, neck and shoulder | MSKEL000039 | 29.75 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 70 | Occupation | SOCIO000006 | 29.69 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 71 | Forced expiratory volume, FEV | RESPI000019 | 29.51 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 72 | Oesophageal disorder | GASTR000050 | 29.17 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 73 | Pelvic morphology | BMORP000021 | 29.14 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 74 | Ankle spacing width | MSKEL000056 | 29.06 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 75 | Ventricular mass | CARDI000012 | 28.25 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 76 | GFER/MAVS ratio | PRORT001205 | 27.70 | Protein ratios | Myeloid | 0 | 3 | 9 | 14 | |
| 77 | Carotid intima-media thickness | VASCU000053 | 27.50 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 78 | PRR15 levels | PROLV001641 | 26.91 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 79 | Sciatica | NEURO000033 | 26.70 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 80 | Body fat percentage | BCOMP000004 | 26.68 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 81 | Implantable cardioverter-defibrillator | CARDI000050 | 26.61 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 82 | Retinal nerve fibre layer thickness | OPHTH000031 | 26.38 | Ophthalmic | Pancreatic epithelium | 8 | 0 | 3 | 8 | |
| 83 | AOC3/ITGB1 ratio | PRORT000113 | 25.91 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 84 | Arm fat percentage | BCOMP000012 | 25.87 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 85 | TSTA3 levels | PROLV002118 | 25.85 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 86 | TNN levels | PROLV002083 | 25.60 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 87 | BCAN/NPTXR ratio | PRORT000219 | 25.43 | Protein ratios | Stromal / connective | 9 | 1 | 6 | 7 | |
| 88 | Forced vital capacity, FVC | RESPI000020 | 25.18 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 89 | Connective tissue disorder | MSKEL000060 | 24.67 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 90 | BCAN/NCAN ratio | PRORT000218 | 24.55 | Protein ratios | Granulosa cell | 5 | 5 | 8 | 16 | |
| 91 | MAMDC2 levels | PROLV001258 | 24.24 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 92 | TCTN3 levels | PROLV002005 | 23.98 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 93 | Passive smoking | MISCL000007 | 23.95 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 94 | Sedentary behaviour | BEHAV000008 | 23.95 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 95 | GGT1/MME ratio | PRORT001214 | 23.90 | Protein ratios | Hepatocyte | 39 | 1 | 5 | 12 | |
| 96 | CDKN1A/TBL1X ratio | PRORT000573 | 23.76 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 97 | PER3 levels | PROLV001537 | 23.65 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 98 | Hospital stay | MISCL000024 | 23.63 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 99 | IFIT2 levels | PROLV001016 | 23.14 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 100 | Narcolepsy | NEURO000036 | 22.94 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 101 | Heart rate | CARDI000021 | 22.93 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 102 | CXADR levels | PROLV000574 | 22.88 | Protein levels | Hepatocyte | 49 | 1 | 5 | 14 | |
| 103 | Occupational physical activity | BEHAV000006 | 22.80 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 104 | AXIN1/CDKN1A ratio | PRORT000166 | 22.79 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 105 | Polyamine metabolites | METAB000059 | 22.56 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 106 | Leukoencephalopathy | NEURO000004 | 22.46 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 107 | RSPO1/SFRP1 ratio | PRORT001751 | 22.43 | Protein ratios | Hepatocyte | 0 | 1 | 5 | 8 | |
| 108 | Triglycerides x psychiatric interaction | LIPID000040 | 22.31 | Lipids | Hepatocyte | 86 | 2 | 7 | 21 | |
| 109 | FKBP4/RWDD1 ratio | PRORT001154 | 22.25 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 5 | 5 | |
| 110 | Shift work | SOCIO000008 | 21.78 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 111 | Pre-existing hypertension, pregnancy | VASCU000044 | 21.50 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 112 | NCK2/PLA2G4A ratio | PRORT001574 | 21.22 | Protein ratios | Granulosa cell | 1 | 4 | 15 | 24 | |
| 113 | Optic cup area | OPHTH000028 | 20.99 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 114 | ALDH1A1/CA2 ratio | PRORT000077 | 20.74 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 115 | ACE2/GGT1 ratio | PRORT000011 | 20.65 | Protein ratios | Hepatocyte | 57 | 1 | 5 | 13 | |
| 116 | Liver enzyme elevation | HPBIL000019 | 20.65 | Hepatopancreatobiliary | Myeloid | 3 | 2 | 6 | 24 | |
| 117 | Ascites | HPBIL000020 | 20.62 | Hepatopancreatobiliary | Vascular | 1 | 1 | 7 | 23 | |
| 118 | ADM/CLMP ratio | PRORT000045 | 20.49 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 119 | Cancer, Respiratory system | MALIG000027 | 20.36 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 120 | Retinal pigment epithelium thickness | OPHTH000042 | 20.35 | Ophthalmic | Myeloid | 6 | 3 | 12 | 13 | |
| 121 | Digital deformity | MSKEL000053 | 20.09 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 122 | Fat mass | BCOMP000005 | 19.86 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 123 | CRIM1/NRP2 ratio | PRORT000760 | 19.84 | Protein ratios | Vascular | 11 | 3 | 12 | 17 | |
| 124 | THY1/TNFRSF21 ratio | PRORT001836 | 19.79 | Protein ratios | Lymphocyte | 1 | 1 | 4 | 6 | |
| 125 | Low hand grip strength | MSKEL000032 | 19.70 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 126 | Waist-hip ratio | BMORP000014 | 19.68 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 127 | Cortical volume | NIMAG000022 | 19.67 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 128 | Diabetes, type 2 with complication | METBL000033 | 19.61 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 129 | Joint disorder | MSKEL000015 | 19.58 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 130 | Pain, chronic | MSKEL000034 | 19.48 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 131 | Alcohol consumption | PSYCH000041 | 19.47 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 132 | Nerve entrapment syndrome | NEURO000028 | 19.06 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 133 | Peripheral nerve disorder | NEURO000031 | 18.97 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 134 | Medication, angiotensin receptor blocker | VASCU000029 | 18.86 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 135 | IGFBP6/MFAP5 ratio | PRORT001336 | 18.72 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 136 | C3 levels | PROLV000232 | 18.36 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 137 | PSRC1 levels | PROLV001662 | 18.36 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 138 | Financial satisfaction | SOCIO000024 | 18.28 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 139 | LRP11/ROR1 ratio | PRORT001461 | 18.27 | Protein ratios | Vascular | 0 | 0 | 4 | 10 | |
| 140 | Administrative status | MISCL000021 | 18.24 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 141 | Urinary retention | NEPHR000015 | 18.18 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 142 | HEXIM1/IPCEF1 ratio | PRORT001277 | 18.11 | Protein ratios | Neural / glial | 2 | 1 | 5 | 16 | |
| 143 | A body shape index, ABSI | BMORP000001 | 18.07 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 144 | Cardiomyopathy | CARDI000040 | 18.00 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 145 | CCDC50 levels | PROLV000275 | 18.00 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 146 | Barrett's oesophagus | GASTR000046 | 17.98 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 147 | GRAP2/PTPN6 ratio | PRORT001244 | 17.95 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 12 | |
| 148 | CA3/HMBS ratio | PRORT000280 | 17.90 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 149 | LRP11 levels | PROLV001230 | 17.87 | Protein levels | Vascular | 22 | 0 | 8 | 22 | |
| 150 | LPL levels | PROLV001222 | 17.85 | Protein levels | Hepatocyte | 51 | 2 | 6 | 10 | |
| 151 | TNC levels | PROLV002052 | 17.68 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 152 | Liver volume | HPBIL000025 | 17.53 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 153 | Diabetes, with complication | METBL000035 | 17.38 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 154 | Body proportion | BMORP000019 | 17.37 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 155 | BST2/MME ratio | PRORT000254 | 17.29 | Protein ratios | Renal epithelium | 5 | 0 | 6 | 12 | |
| 156 | EIF1AX levels | PROLV000692 | 17.03 | Protein levels | Myeloid | 1 | 1 | 5 | 7 | |
| 157 | Sexual behaviour | BEHAV000012 | 16.98 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 158 | NAAA/SMPD1 ratio | PRORT001569 | 16.95 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 159 | BPIFB2 levels | PROLV000211 | 16.95 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 160 | ACY1/SCLY ratio | PRORT000021 | 16.94 | Protein ratios | Hepatocyte | 6 | 3 | 12 | 17 | |
| 161 | Water consumption | DTSUP000004 | 16.83 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 162 | Facial nerve palsy | NEURO000026 | 16.63 | Neurologic | Neural / glial | 0 | 1 | 9 | 27 | |
| 163 | Valvular heart disease | CARDI000054 | 16.52 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 164 | Testicular dysfunction | REPRO000016 | 16.52 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 165 | Fasciectomy | MSKEL000045 | 16.51 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 166 | MENT levels | PROLV001296 | 16.49 | Protein levels | Hepatocyte | 57 | 2 | 10 | 14 | |
| 167 | Nerve root disorder | NEURO000030 | 16.48 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 168 | Bacterial intestinal infection | IMMUN000052 | 16.45 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 169 | PRTG levels | PROLV001650 | 16.39 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 170 | Heel quantitative ultrasound | MSKEL000005 | 16.37 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 171 | NSFL1C/PSMG3 ratio | PRORT001599 | 16.36 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 172 | Cancer, Other | MALIG000023 | 16.32 | Malignancy | B / plasma cell | 0 | 2 | 12 | 21 | |
| 173 | Sodium | METAB000050 | 16.27 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 174 | Heart failure | CARDI000007 | 16.25 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 175 | FAS levels | PROLV000770 | 16.14 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 176 | PRSS8 levels | PROLV001648 | 15.96 | Protein levels | Epithelial | 26 | 1 | 5 | 8 | |
| 177 | KDR/VWF ratio | PRORT001402 | 15.95 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 178 | Peripheral neuropathy | NEURO000032 | 15.89 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 179 | Hearing loss, sensorineural | AUDIO000008 | 15.88 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 180 | Cerebrovascular disease | VASCU000013 | 15.80 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 181 | Reaction time | PSYCH000010 | 15.70 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 182 | Vitreous disorder | OPHTH000047 | 15.69 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 183 | Intelligence | PSYCH000004 | 15.41 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 184 | Pneumonopathy | RESPI000016 | 15.22 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 185 | Heart failure, with coronary heart disease | CARDI000005 | 15.19 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 186 | Corneal keratometry | OPHTH000006 | 15.16 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 187 | Musculoskeletal soft tissue disorder | MSKEL000029 | 15.12 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 188 | ANGPTL2 levels | PROLV000096 | 15.10 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 189 | SCARA5/TNC ratio | PRORT001760 | 15.08 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 190 | TNC/VCAM1 ratio | PRORT001843 | 15.00 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 191 | Paroxysmal neurological disorder | NEURO000035 | 14.87 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 192 | SPESP1 levels | PROLV001926 | 14.86 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 193 | Female genital tract polyp | REPRO000009 | 14.80 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 194 | CST3/IGFBP6 ratio | PRORT000783 | 14.78 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 195 | SESTD1 levels | PROLV001838 | 14.77 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 196 | MEPE levels | PROLV001299 | 14.61 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 197 | Educational attainment | SOCIO000002 | 14.59 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 198 | CDKN1A/TXLNA ratio | PRORT000575 | 14.34 | Protein ratios | Myeloid | 15 | 4 | 12 | 14 | |
| 199 | Cortical thickness | NIMAG000010 | 14.33 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 200 | Processing speed | PSYCH000008 | 14.30 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 201 | Chronic bronchitis | RESPI000010 | 14.27 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 202 | Spinal stenosis | MSKEL000078 | 14.25 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 203 | Anaemia of chronic disease | HEMAT000002 | 14.18 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 204 | Hypothyroidism, secondary | ENDOC000015 | 14.17 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 205 | Supplement use, mineral or vitamin | DTSUP000026 | 14.14 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 206 | Waist circumference, adjusted for BMI | BMORP000006 | 14.12 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 207 | Tinnitus | AUDIO000014 | 14.04 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 208 | ECG morphology, adjusted | ECGRM000001 | 13.87 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 209 | Gut microbial abundance, Staphylococcus | GASTR000036 | 13.83 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 210 | Pain, none | MSKEL000041 | 13.82 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 211 | Sex-differentiated cardiometabolic traits | MISCL000002 | 13.82 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 212 | JAM2 levels | PROLV001124 | 13.80 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 213 | CD84/TREML2 ratio | PRORT000529 | 13.70 | Protein ratios | B / plasma cell | 3 | 2 | 4 | 10 | |
| 214 | BAIAP2/MME ratio | PRORT000203 | 13.70 | Protein ratios | Hepatocyte | 15 | 1 | 6 | 6 | |
| 215 | Hospital admission | MISCL000022 | 13.63 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 216 | CALCOCO1/TJAP1 ratio | PRORT000303 | 13.61 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 217 | Uterine disorder | REPRO000043 | 13.58 | Reproductive | Vascular | 0 | 0 | 2 | 6 | |
| 218 | Corpus callosum volume | NIMAG000021 | 13.52 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 219 | Intervertebral disc disorder | MSKEL000076 | 13.47 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 220 | Acquired absence of organs | MISCL000027 | 13.45 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 221 | CFH levels | PROLV000413 | 13.44 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 222 | Occupational attainment | SOCIO000007 | 13.43 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 223 | Spondylosis | MSKEL000081 | 13.41 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 224 | Hypoxaemia | RESPI000029 | 13.39 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 225 | Heart rate, exercise | CARDI000017 | 13.37 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 226 | PBLD levels | PROLV001500 | 13.34 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 227 | MYOC levels | PROLV001363 | 13.31 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 228 | PYY levels | PROLV001690 | 13.28 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 229 | Spine surgery | MSKEL000051 | 13.28 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 230 | Gastritis and duodenitis | GASTR000049 | 13.21 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 231 | Retirement wellbeing | SOCIO000027 | 13.18 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 232 | EFNA4/LAYN ratio | PRORT000990 | 13.14 | Protein ratios | Muscle / cardiac | 3 | 3 | 8 | 13 | |
| 233 | Frailty, poorer cognition | PSYCH000001 | 13.13 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 234 | Coffee preference | DTSUP000002 | 13.10 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 235 | ENO2/SCRN1 ratio | PRORT001030 | 13.05 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 4 | |
| 236 | Social activity | SOCIO000020 | 13.03 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 237 | Fracture fixation | MSKEL000047 | 12.96 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 238 | RGMB/THY1 ratio | PRORT001738 | 12.89 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 12 | |
| 239 | CASP3/LYN ratio | PRORT000314 | 12.87 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 240 | COMP/THBS4 ratio | PRORT000714 | 12.84 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 241 | Medication, analgesic | MISCL000034 | 12.84 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 242 | APP/NID2 ratio | PRORT000129 | 12.78 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 243 | Consultant specialty, general medicine | MISCL000016 | 12.74 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 244 | Aortic elasticity | VASCU000049 | 12.64 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 245 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 12.61 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 246 | Ventricular volume | CARDI000015 | 12.58 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 247 | Meat preference | DTSUP000015 | 12.56 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 248 | ADAMTS8/FAP ratio | PRORT000026 | 12.53 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 249 | ECG-predicted BMI discrepancy | BMORP000008 | 12.45 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 250 | CCL22 levels | PROLV000289 | 12.41 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 251 | Body mass index, BMI | BMORP000002 | 12.40 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 252 | AIFM1/SIRT2 ratio | PRORT000061 | 12.40 | Protein ratios | Hepatocyte | 13 | 1 | 7 | 13 | |
| 253 | ICA1/TANK ratio | PRORT001320 | 12.38 | Protein ratios | Neural / glial | 0 | 3 | 4 | 9 | |
| 254 | Chronic respiratory disease | RESPI000003 | 12.37 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 255 | Fibromuscular dysplasia | VASCU000024 | 12.29 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 256 | Malocclusion | DENTA000008 | 12.29 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 257 | Bone mineral density | MSKEL000004 | 12.28 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 258 | Cellulitis and abscess | IMMUN000055 | 12.25 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 259 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 12.21 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 260 | Insomnia | PSYCH000038 | 12.19 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 261 | Family history, dyslipidaemia | METBL000010 | 12.15 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 262 | Professional qualification | SOCIO000003 | 12.13 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 263 | Dyspnoea | RESPI000028 | 12.10 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 264 | Sleep disorder | PSYCH000039 | 12.05 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 265 | PMVK/PRTFDC1 ratio | PRORT001693 | 11.99 | Protein ratios | Muscle / cardiac | 1 | 2 | 11 | 12 | |
| 266 | Retinal vascular disorder | OPHTH000044 | 11.93 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 267 | CHRDL1/SMOC2 ratio | PRORT000614 | 11.91 | Protein ratios | Adipose | 3 | 3 | 7 | 14 | |
| 268 | DHX58 levels | PROLV000617 | 11.89 | Protein levels | Hepatocyte | 1 | 4 | 9 | 28 | |
| 269 | Cortical surface area | NIMAG000009 | 11.88 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 270 | Triglycerides, IDL | LIPID000034 | 11.86 | Lipids | Hepatocyte | 918 | 2 | 9 | 15 | |
| 271 | Atrial volume | CARDI000009 | 11.71 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 272 | SSH3 levels | PROLV001949 | 11.70 | Protein levels | Stromal / connective | — | 1 | 10 | 6 | |
| 273 | PAPPA levels | PROLV001495 | 11.66 | Protein levels | Hematopoietic progenitor | 59 | 1 | 5 | 8 | |
| 274 | PADI4 levels | PROLV001484 | 11.65 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 275 | FAM3D levels | PROLV000768 | 11.60 | Protein levels | Epithelial | 7 | 0 | 5 | 8 | |
| 276 | IGFBP2 levels | PROLV001029 | 11.58 | Protein levels | Muscle / cardiac | 58 | 2 | 4 | 14 | |
| 277 | IL1RL1 levels | PROLV001063 | 11.58 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 278 | Aortic valve disease | CARDI000053 | 11.48 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 279 | NPHS2 levels | PROLV001422 | 11.47 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 280 | Cancer, Ovary | MALIG000024 | 11.45 | Malignancy | Gastrointestinal epithelium | 23 | 0 | 7 | 13 | |
| 281 | FLRT2/GFRA3 ratio | PRORT001161 | 11.42 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 282 | Medication, chronic lung disease | RESPI000006 | 11.41 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 283 | ZNF830 levels | PROLV002212 | 11.38 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 284 | Skin ulcer | DERMA000044 | 11.35 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 285 | Pyloric stenosis | GASTR000052 | 11.31 | Gastrointestinal | B / plasma cell | 0 | 0 | 6 | 6 | |
| 286 | MCAM/NCAM1 ratio | PRORT001505 | 11.31 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 287 | Panic attack | PSYCH000031 | 11.24 | Psychiatric | Muscle / cardiac | 0 | 1 | 7 | 4 | |
| 288 | COL4A1 levels | PROLV000490 | 11.16 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 289 | PLAUR/PRSS8 ratio | PRORT001679 | 11.13 | Protein ratios | Epithelial | 37 | 2 | 11 | 13 | |
| 290 | Pain, back | MSKEL000033 | 11.12 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 291 | ADAMTS15/CLMP ratio | PRORT000024 | 11.06 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 292 | CTSF/NAAA ratio | PRORT000801 | 11.00 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 293 | ALDH1A1/CA3 ratio | PRORT000078 | 10.97 | Protein ratios | Myeloid | 27 | 5 | 10 | 28 | |
| 294 | Pregnancy termination | BEHAV000010 | 10.91 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 295 | Self-rated health | MISCL000013 | 10.90 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 296 | CEACAM8/VNN2 ratio | PRORT000590 | 10.85 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 297 | Medication, anti-obesity | METBL000026 | 10.80 | Metabolic | Neural / glial | 0 | 1 | 4 | 11 | |
| 298 | Upper respiratory tract disease | RESPI000042 | 10.79 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 299 | FGFBP1 levels | PROLV000798 | 10.75 | Protein levels | Myeloid | 102 | 3 | 10 | 12 | |
| 300 | SH2B3/TBL1X ratio | PRORT001784 | 10.73 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 301 | Hypokalaemia | METBL000006 | 10.72 | Metabolic | Hepatocyte | 0 | 1 | 4 | 15 | |
| 302 | PSPN levels | PROLV001661 | 10.70 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 303 | Aortic aneurysm | VASCU000002 | 10.55 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 304 | Synovium, tendon and bursa disorder | MSKEL000057 | 10.54 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 305 | LAT2/YES1 ratio | PRORT001432 | 10.53 | Protein ratios | Hematopoietic progenitor | 10 | 2 | 6 | 7 | |
| 306 | Hypertensive heart disease | CARDI000038 | 10.46 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 307 | FETUB levels | PROLV000790 | 10.43 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 308 | Headache | NEURO000009 | 10.39 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 309 | CLEC4A levels | PROLV000450 | 10.37 | Protein levels | Myeloid | 121 | 3 | 13 | 20 | |
| 310 | F11 levels | PROLV000741 | 10.36 | Protein levels | Hepatocyte | 103 | 3 | 8 | 13 | |
| 311 | COMP levels | PROLV000496 | 10.30 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 312 | Memory function | PSYCH000007 | 10.28 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 313 | LDLR levels | PROLV001194 | 10.24 | Protein levels | Myeloid | 136 | 0 | 4 | 9 | |
| 314 | CA1/TGM2 ratio | PRORT000270 | 10.21 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 315 | DSG3/DSG4 ratio | PRORT000952 | 10.18 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 316 | KRT5 levels | PROLV001167 | 10.18 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 317 | GAST levels | PROLV000857 | 10.15 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 318 | CPA2 levels | PROLV000502 | 10.12 | Protein levels | Pancreatic epithelium | 57 | 0 | 5 | 5 | |
| 319 | PPIE levels | PROLV001607 | 10.12 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 320 | ECG morphology, unadjusted | ECGRM000002 | 10.09 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 321 | Autoimmune hepatitis | IMMUN000024 | 10.08 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 322 | SLPI levels | PROLV001892 | 10.01 | Protein levels | Cutaneous epithelium | 0 | 0 | 11 | 9 | |
| 323 | Soft tissue disorder | MSKEL000069 | 9.97 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 324 | HPCAL1/PMVK ratio | PRORT001298 | 9.94 | Protein ratios | Myeloid | 1 | 3 | 11 | 25 | |
| 325 | PDP1 levels | PROLV001530 | 9.92 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 326 | Ocular alignment procedures | OPHTH000026 | 9.89 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 327 | SMOC2 levels | PROLV001900 | 9.87 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 328 | Reproductive timing | BEHAV000011 | 9.84 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 329 | Medication, GERD | GASTR000014 | 9.84 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 330 | BACH1/EIF4G1 ratio | PRORT000194 | 9.84 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 20 | |
| 331 | Hair characteristics | DERMA000031 | 9.83 | Dermatologic | Adipose | 1 | 1 | 1 | 0 | |
| 332 | Glutamate metabolites | METAB000005 | 9.81 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 333 | Oedema | MISCL000012 | 9.81 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 334 | CLUL1 levels | PROLV000468 | 9.80 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 335 | FAP/LRRN1 ratio | PRORT001116 | 9.79 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 336 | Stroke | VASCU000017 | 9.76 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 337 | Parental longevity | AGING000003 | 9.75 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 338 | Operation, reproductive | REPRO000042 | 9.72 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 339 | CHRDL1 levels | PROLV000433 | 9.66 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 340 | Blood pressure, BP, pulse | VASCU000010 | 9.65 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 341 | FSTL3/LTBR ratio | PRORT001181 | 9.64 | Protein ratios | Vascular | 1 | 2 | 8 | 11 | |
| 342 | CAPN3 levels | PROLV000263 | 9.63 | Protein levels | B / plasma cell | 0 | 2 | 9 | 11 | |
| 343 | ALDH1A1/PKLR ratio | PRORT000079 | 9.60 | Protein ratios | Myeloid | 11 | 3 | 10 | 21 | |
| 344 | Emphysema | RESPI000011 | 9.59 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 345 | NEFL levels | PROLV001389 | 9.59 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 346 | LY6D/PLA2G10 ratio | PRORT001469 | 9.53 | Protein ratios | Vascular | 48 | 3 | 10 | 17 | |
| 347 | APOM/MCAM ratio | PRORT000119 | 9.52 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 348 | Household size | SOCIO000011 | 9.47 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 349 | Cholesterol, IDL | LIPID000005 | 9.46 | Lipids | Hepatocyte | 692 | 1 | 8 | 15 | |
| 350 | Consultant specialty, anaesthetics | MISCL000015 | 9.45 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 351 | CEACAM1/GGT1 ratio | PRORT000586 | 9.43 | Protein ratios | Hepatocyte | 33 | 1 | 4 | 9 | |
| 352 | BAP18 levels | PROLV000179 | 9.34 | Protein levels | Vascular | 44 | 4 | 13 | 39 | |
| 353 | Biliverdin | HPBIL000018 | 9.33 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 354 | MCAM levels | PROLV001283 | 9.31 | Protein levels | Granulosa cell | 164 | 2 | 6 | 15 | |
| 355 | Male genital disorder | REPRO000013 | 9.30 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 356 | Thyrotoxicosis | ENDOC000024 | 9.29 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 357 | Blood pressure, BP, diastolic | VASCU000009 | 9.25 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 358 | ENO2/RWDD1 ratio | PRORT001029 | 9.25 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 359 | Dyslipidaemia | METBL000020 | 9.25 | Metabolic | Hepatocyte | 416 | 1 | 6 | 10 | |
| 360 | Electronic device use | BEHAV000017 | 9.21 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 361 | Grey matter volume | NIMAG000023 | 9.21 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 362 | Pulmonary nodule | RESPI000018 | 9.16 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 363 | Menstrual disorder | REPRO000021 | 9.15 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 364 | Commuting transport | SOCIO000004 | 9.15 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 365 | Medication, analgesic or antidepressant | MISCL000033 | 9.15 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 366 | FAM13A levels | PROLV000759 | 9.14 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 367 | AXIN1/CALCOCO1 ratio | PRORT000165 | 9.13 | Protein ratios | Granulosa cell | 3 | 4 | 14 | 33 | |
| 368 | Hip circumference | BMORP000011 | 9.08 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 369 | CD300C/MANSC1 ratio | PRORT000427 | 9.05 | Protein ratios | Myeloid | 13 | 3 | 8 | 22 | |
| 370 | PDGFA/SERPINE1 ratio | PRORT001635 | 9.03 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 371 | REG4/SPINK4 ratio | PRORT001733 | 8.99 | Protein ratios | Myeloid | 0 | 0 | 2 | 10 | |
| 372 | Refractive errors | OPHTH000034 | 8.99 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 373 | CRADD/FADD ratio | PRORT000745 | 8.96 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 374 | Triglycerides, LDL | LIPID000035 | 8.95 | Lipids | Hepatocyte | 1,174 | 2 | 10 | 12 | |
| 375 | White matter microstructure | NIMAG000013 | 8.94 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 376 | STK11/USP8 ratio | PRORT001819 | 8.94 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 14 | |
| 377 | ECG QRS-T angle | CARDI000033 | 8.91 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 378 | Ventricular wall thickness | CARDI000016 | 8.90 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 379 | Cholesteryl esters | LIPID000019 | 8.86 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 380 | SERPINE1/SPARC ratio | PRORT001778 | 8.84 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 13 | |
| 381 | LTBP2/PDGFRA ratio | PRORT001465 | 8.82 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 382 | MELTF levels | PROLV001295 | 8.81 | Protein levels | Myeloid | 23 | 3 | 9 | 11 | |
| 383 | Amino acid metabolism disorder | METBL000001 | 8.78 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 384 | NT5C1A levels | PROLV001439 | 8.76 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 385 | Migraine | NEURO000010 | 8.76 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 386 | Family history, chronic disease | MISCL000009 | 8.75 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 387 | CLEC1A/GPR37 ratio | PRORT000631 | 8.72 | Protein ratios | Muscle / cardiac | 25 | 3 | 8 | 20 | |
| 388 | Cereal preference | DTSUP000010 | 8.72 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 389 | CD300C/FOLR2 ratio | PRORT000423 | 8.69 | Protein ratios | Myeloid | 63 | 2 | 9 | 10 | |
| 390 | CA13/TIA1 ratio | PRORT000272 | 8.68 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 25 | |
| 391 | CD58/MCAM ratio | PRORT000476 | 8.67 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 392 | Placental weight | REPRO000026 | 8.65 | Reproductive | Hepatocyte | 59 | 3 | 8 | 17 | |
| 393 | Cardiovascular age gap | CARDI000001 | 8.63 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 394 | SCARA3 levels | PROLV001779 | 8.63 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 395 | Corrective lens use | OPHTH000032 | 8.61 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 396 | Phosphatidylglycerols | LIPID000060 | 8.59 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 397 | Peripheral vascular disease | VASCU000043 | 8.58 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 398 | Food preparation preference | DTSUP000021 | 8.57 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 399 | ERBIN/LYN ratio | PRORT001049 | 8.57 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 400 | Inflammation and poor diet | MISCL000001 | 8.57 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 401 | NPTXR levels | PROLV001428 | 8.56 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 402 | Brain neuroimaging feature | NIMAG000005 | 8.53 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 403 | Medication, proton pump inhibitor | GASTR000017 | 8.52 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 404 | PLAUR/TREM2 ratio | PRORT001680 | 8.50 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 405 | Alport syndrome | NEPHR000003 | 8.47 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 406 | Fall risk | MSKEL000043 | 8.46 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 407 | GRPEL1/MME ratio | PRORT001248 | 8.44 | Protein ratios | Hepatocyte | 24 | 1 | 6 | 6 | |
| 408 | Osteoporosis | MSKEL000010 | 8.44 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 409 | Oestrogen metabolite | ENDOC000009 | 8.43 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 410 | Obstetric trauma | REPRO000039 | 8.38 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 411 | Drink temperature | DTSUP000003 | 8.36 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 412 | Smoking effects on COPD | RESPI000012 | 8.36 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 413 | BOC levels | PROLV000207 | 8.36 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 414 | Aneurysm | VASCU000001 | 8.34 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 415 | CCDC80/CCL27 ratio | PRORT000332 | 8.33 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 416 | Osteoarthritis, OA | MSKEL000012 | 8.33 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 417 | Fatty acids, polyunsaturated | LIPID000026 | 8.33 | Lipids | Hepatocyte | 953 | 2 | 7 | 12 | |
| 418 | Methionine metabolites | METAB000010 | 8.30 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 419 | Tubulointerstitial kidney disease | NEPHR000025 | 8.29 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 420 | CALCOCO1/INPPL1 ratio | PRORT000296 | 8.29 | Protein ratios | Granulosa cell | 0 | 2 | 11 | 25 | |
| 421 | Phosphatidylinositols | LIPID000061 | 8.23 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 422 | MME/NT5E ratio | PRORT001540 | 8.19 | Protein ratios | Hepatocyte | 24 | 1 | 4 | 9 | |
| 423 | Hearing loss | AUDIO000013 | 8.19 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 424 | EIF3J levels | PROLV000694 | 8.18 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 425 | NTPROBNP levels | PROLV001446 | 8.16 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 426 | ENG/NOTCH1 ratio | PRORT001018 | 8.16 | Protein ratios | Vascular | 3 | 2 | 7 | 16 | |
| 427 | Raynaud phenomenon | VASCU000060 | 8.13 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 428 | KYAT1 levels | PROLV001169 | 8.11 | Protein levels | Neural / glial | 2 | 2 | 8 | 16 | |
| 429 | Obesity | METBL000008 | 8.10 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 430 | ART3 levels | PROLV000147 | 8.09 | Protein levels | Muscle / cardiac | 82 | 2 | 6 | 7 | |
| 431 | FSHB levels | PROLV000828 | 8.06 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 432 | Hypercalcaemia | METBL000005 | 8.06 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 433 | LGALS3 levels | PROLV001202 | 8.06 | Protein levels | Vascular | 28 | 1 | 2 | 8 | |
| 434 | Bone marrow fat fraction, spine | MSKEL000002 | 8.05 | Musculoskeletal | Vascular | 67 | 2 | 8 | 16 | |
| 435 | Spondylopathy | MSKEL000080 | 8.05 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 436 | Fatty acids metabolites | METAB000052 | 8.03 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 437 | Sleep duration | PSYCH000040 | 8.03 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 438 | Thrombophlebitis | VASCU000063 | 8.00 | Vascular | Hepatocyte | 61 | 1 | 4 | 9 | |
| 439 | Heart disease | CARDI000036 | 7.98 | Cardiac | Muscle / cardiac | 66 | 4 | 8 | 25 | |
| 440 | Glycine metabolites | METAB000007 | 7.98 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 441 | CALCOCO1/VPS53 ratio | PRORT000304 | 7.97 | Protein ratios | Epithelial | 0 | 2 | 13 | 39 | |
| 442 | Vestibular disorder | AUDIO000022 | 7.96 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 443 | APOA4 levels | PROLV000119 | 7.94 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 444 | CLIC5 levels | PROLV000458 | 7.93 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 445 | COMP/ICAM1 ratio | PRORT000710 | 7.92 | Protein ratios | Myeloid | 38 | 4 | 10 | 17 | |
| 446 | INSL4 levels | PROLV001092 | 7.91 | Protein levels | Muscle / cardiac | 3 | 2 | 4 | 12 | |
| 447 | Hearing difficulty | AUDIO000012 | 7.89 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 448 | ADH4/DCXR ratio | PRORT000039 | 7.89 | Protein ratios | Hepatocyte | 17 | 4 | 11 | 18 | |
| 449 | THBS4 levels | PROLV002027 | 7.89 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 450 | PIK3AP1/PSMG3 ratio | PRORT001664 | 7.88 | Protein ratios | Lymphocyte | 1 | 1 | 6 | 9 | |
| 451 | FAM177A1 levels | PROLV000764 | 7.84 | Protein levels | Gastrointestinal epithelium | 10 | 1 | 7 | 14 | |
| 452 | HSD11B1/SMPD1 ratio | PRORT001302 | 7.83 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 453 | PPCDC levels | PROLV001605 | 7.83 | Protein levels | Vascular | 11 | 3 | 5 | 7 | |
| 454 | FAM151A levels | PROLV000760 | 7.81 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 455 | COL9A1 levels | PROLV000493 | 7.81 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 456 | COL1A1 levels | PROLV000485 | 7.80 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 457 | LCN15 levels | PROLV001191 | 7.79 | Protein levels | Gastrointestinal epithelium | 4 | 0 | 4 | 8 | |
| 458 | IGFBP4/OGN ratio | PRORT001335 | 7.77 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 459 | Cholesterol, total | LIPID000014 | 7.76 | Lipids | Hepatocyte | 1,261 | 1 | 6 | 10 | |
| 460 | Waist circumference | BMORP000013 | 7.74 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 461 | Pancreas fat | HPBIL000028 | 7.70 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 462 | Body size, birth | BMORP000017 | 7.69 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 463 | BCAM/PCDH17 ratio | PRORT000212 | 7.68 | Protein ratios | Granulosa cell | 32 | 2 | 8 | 14 | |
| 464 | IGFBP6/PTGDS ratio | PRORT001337 | 7.67 | Protein ratios | Myeloid | 19 | 2 | 7 | 18 | |
| 465 | CD93/CLEC14A ratio | PRORT000531 | 7.67 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 466 | CEACAM8/RNASE3 ratio | PRORT000589 | 7.66 | Protein ratios | Hematopoietic progenitor | 2 | 3 | 4 | 11 | |
| 467 | Sleep apnoea | RESPI000035 | 7.66 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 468 | SFRP4 levels | PROLV001846 | 7.65 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 469 | Digestive system symptoms | GASTR000044 | 7.64 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 470 | BLMH levels | PROLV000199 | 7.63 | Protein levels | Myeloid | 63 | 2 | 7 | 14 | |
| 471 | C1QTNF1/COL4A1 ratio | PRORT000263 | 7.63 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 472 | Fatty acids, monounsaturated | LIPID000023 | 7.63 | Lipids | Hepatocyte | 1,143 | 2 | 10 | 17 | |
| 473 | HIP1R levels | PROLV000970 | 7.62 | Protein levels | Myeloid | 1 | 2 | 12 | 23 | |
| 474 | Aortic diameter | VASCU000052 | 7.57 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 475 | EPCAM levels | PROLV000715 | 7.56 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 476 | FGR levels | PROLV000804 | 7.55 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 477 | Glutamine | METAB000021 | 7.55 | Metabolites | Hepatocyte | 401 | 2 | 9 | 18 | |
| 478 | PCDH17/TEK ratio | PRORT001627 | 7.52 | Protein ratios | Vascular | 19 | 2 | 7 | 8 | |
| 479 | CALCOCO1/IKBKG ratio | PRORT000295 | 7.49 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 480 | Healthspan | AGING000004 | 7.47 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 481 | Alcohol use disorder | PSYCH000044 | 7.45 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 482 | Optic disc area | OPHTH000029 | 7.40 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 483 | MFAP4 levels | PROLV001305 | 7.40 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 484 | HEXIM1/TBL1X ratio | PRORT001280 | 7.40 | Protein ratios | Myeloid | 4 | 3 | 12 | 30 | |
| 485 | BLVRB/CA3 ratio | PRORT000240 | 7.39 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 486 | GDF15 levels | PROLV000869 | 7.39 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 487 | FAP/THBS4 ratio | PRORT001117 | 7.38 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 488 | CD300LG/CD93 ratio | PRORT000433 | 7.32 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 489 | CUZD1 levels | PROLV000571 | 7.31 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 490 | PCDH12 levels | PROLV001505 | 7.30 | Protein levels | Neural / glial | 5 | 2 | 5 | 10 | |
| 491 | Iron deficiency anaemia | HEMAT000011 | 7.30 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 492 | CRISP2 levels | PROLV000524 | 7.26 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 493 | Trihexosylceramides | LIPID000073 | 7.25 | Lipids | Granulosa cell | 7 | 2 | 5 | 4 | |
| 494 | Dairy preference | DTSUP000011 | 7.22 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 495 | GLOD4/S100A4 ratio | PRORT001220 | 7.21 | Protein ratios | Epithelial | 8 | 0 | 9 | 9 | |
| 496 | LAYN/PTPRN2 ratio | PRORT001433 | 7.18 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 497 | Ocular refraction | OPHTH000033 | 7.16 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 498 | Acquired foot deformities | MSKEL000052 | 7.13 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 499 | Polymyalgia rheumatica | IMMUN000038 | 7.13 | Immunologic | Myeloid | 34 | 3 | 11 | 14 | |
| 500 | Optic disc morphology | OPHTH000030 | 7.12 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 501 | Immune cell marker, CD8 T cell | HEMAT000023 | 7.12 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 502 | Insulin levels | METBL000040 | 7.11 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 503 | Prolapse, pelvic organ | REPRO000025 | 7.10 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 504 | Fatty acids unsaturation | LIPID000032 | 7.10 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 505 | Benign neoplasm, Ocular | MALIG000005 | 7.09 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 506 | Complement system disorder | IMMUN000048 | 7.09 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 507 | SNAP23/TBL1X ratio | PRORT001794 | 7.08 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 508 | Medication, anti-depressant | PSYCH000019 | 7.05 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 509 | CLEC4G/SEMA3F ratio | PRORT000663 | 7.04 | Protein ratios | Myeloid | 15 | 3 | 11 | 19 | |
| 510 | MCEE levels | PROLV001284 | 7.01 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 511 | MAVS/TBL1X ratio | PRORT001501 | 7.00 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 512 | EGFLAM levels | PROLV000686 | 7.00 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 513 | SLC35G2 levels | PROLV001879 | 6.99 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 514 | Nephritis | NEPHR000024 | 6.98 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 515 | DPP4/ITGB1 ratio | PRORT000944 | 6.97 | Protein ratios | Myeloid | 11 | 3 | 12 | 25 | |
| 516 | LAMP2 levels | PROLV001181 | 6.97 | Protein levels | Myeloid | 51 | 1 | 8 | 7 | |
| 517 | Healthcare cost | SOCIO000025 | 6.95 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 518 | Sphingomyelins | LIPID000072 | 6.93 | Lipids | Hepatocyte | 272 | 1 | 2 | 8 | |
| 519 | Congenital malformation | REPRO000003 | 6.90 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 520 | Tympanic membrane perforation | AUDIO000019 | 6.89 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 521 | FABP2/RBP2 ratio | PRORT001099 | 6.87 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 522 | BCL2L2 levels | PROLV000189 | 6.85 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 523 | Potassium | METAB000049 | 6.84 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 524 | Eyelid disorder | OPHTH000019 | 6.81 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 525 | Personal medical history | MISCL000011 | 6.81 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 526 | Medication, lipid-lowering | METBL000028 | 6.77 | Metabolic | Hepatocyte | 589 | 1 | 7 | 4 | |
| 527 | Hearing difficulty, none | AUDIO000005 | 6.76 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 528 | LGALS8/VWF ratio | PRORT001455 | 6.76 | Protein ratios | Granulosa cell | 1 | 4 | 10 | 24 | |
| 529 | SERPING1 levels | PROLV001834 | 6.72 | Protein levels | Myeloid | 141 | 3 | 12 | 23 | |
| 530 | CST3/CTSZ ratio | PRORT000780 | 6.72 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 14 | |
| 531 | Cerebral aneurysm | VASCU000004 | 6.72 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 532 | ADH4/SORD ratio | PRORT000044 | 6.68 | Protein ratios | Hepatocyte | 24 | 2 | 12 | 24 | |
| 533 | CPA4 levels | PROLV000503 | 6.66 | Protein levels | Myeloid | 3 | 3 | 8 | 8 | |
| 534 | Asparagine | METAB000018 | 6.64 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 535 | PRTN3/RETN ratio | PRORT001711 | 6.64 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 536 | Patellar disorder | MSKEL000018 | 6.63 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 537 | Urbanicity | SOCIO000029 | 6.62 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 538 | IGFBPL1 levels | PROLV001034 | 6.62 | Protein levels | Hepatocyte | 26 | 1 | 4 | 8 | |
| 539 | CKAP4/TNFRSF4 ratio | PRORT000624 | 6.62 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 540 | Operation, hernia | GASTR000040 | 6.62 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 541 | Vaccination | IMMUN000085 | 6.61 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 542 | Depression or anxiety | PSYCH000025 | 6.60 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 543 | Amygdala volume | NIMAG000014 | 6.59 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 544 | Fibroblastic disorder | MSKEL000064 | 6.57 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 545 | Cancer, Lung | MALIG000019 | 6.56 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 546 | Eye disorder | OPHTH000008 | 6.55 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 547 | LAMP1 levels | PROLV001180 | 6.55 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 548 | Medication, coronary artery disease | VASCU000037 | 6.55 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 549 | Nail disorder | DERMA000033 | 6.54 | Dermatologic | Lymphocyte | 1 | 2 | 11 | 24 | |
| 550 | Cholesterol, VLDL free | LIPID000008 | 6.54 | Lipids | Hepatocyte | 1,347 | 2 | 8 | 17 | |
| 551 | SERPINA5 levels | PROLV001819 | 6.52 | Protein levels | Hepatocyte | 98 | 1 | 5 | 10 | |
| 552 | PITHD1 levels | PROLV001563 | 6.52 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 553 | ITGB5/S100A4 ratio | PRORT001392 | 6.50 | Protein ratios | Myeloid | 11 | 3 | 8 | 10 | |
| 554 | Operation, cardiac | CARDI000046 | 6.50 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 555 | BST2/CXADR ratio | PRORT000253 | 6.50 | Protein ratios | Myeloid | 12 | 2 | 7 | 12 | |
| 556 | ADGRE2/IFNGR1 ratio | PRORT000029 | 6.49 | Protein ratios | Myeloid | 51 | 2 | 10 | 15 | |
| 557 | MFAP5 levels | PROLV001306 | 6.49 | Protein levels | Vascular | 14 | 2 | 7 | 13 | |
| 558 | PCSK9 levels | PROLV001512 | 6.48 | Protein levels | Hepatocyte | 87 | 1 | 5 | 8 | |
| 559 | Dysmenorrhea | REPRO000019 | 6.47 | Reproductive | Myeloid | 1 | 2 | 6 | 12 | |
| 560 | FLT1/VEGFA ratio | PRORT001164 | 6.47 | Protein ratios | Muscle / cardiac | 9 | 2 | 6 | 11 | |
| 561 | SNCA levels | PROLV001908 | 6.46 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 562 | ADH4/SCLY ratio | PRORT000043 | 6.43 | Protein ratios | Hepatocyte | 18 | 4 | 15 | 30 | |
| 563 | Family history, lung cancer | MALIG000039 | 6.42 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 564 | PHLDB1 levels | PROLV001550 | 6.41 | Protein levels | Myeloid | 1 | 1 | 6 | 16 | |
| 565 | Medication, benign prostatic hyperplasia | REPRO000017 | 6.40 | Reproductive | Respiratory epithelium | 14 | 0 | 4 | 4 | |
| 566 | Ventricular function | CARDI000008 | 6.39 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 567 | PRKAR1A levels | PROLV001631 | 6.39 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 568 | Cholesteryl esters, IDL | LIPID000016 | 6.39 | Lipids | Hepatocyte | 572 | 1 | 8 | 17 | |
| 569 | Lysophosphatidylethanolamines | LIPID000055 | 6.35 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 570 | HbA1c | METBL000039 | 6.33 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 571 | Fatty acids, saturated | LIPID000027 | 6.33 | Lipids | Hepatocyte | 696 | 1 | 7 | 12 | |
| 572 | Hypertriglyceridaemia | METBL000023 | 6.32 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 573 | MAD1L1 levels | PROLV001257 | 6.31 | Protein levels | Myeloid | 6 | 5 | 12 | 26 | |
| 574 | GFAP levels | PROLV000874 | 6.31 | Protein levels | Myeloid | 2 | 3 | 11 | 10 | |
| 575 | Exotropia | OPHTH000022 | 6.29 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 576 | ZBTB17 levels | PROLV002210 | 6.29 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 577 | Choroid plexus volume | NIMAG000020 | 6.28 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 578 | Parkinson disease | NEURO000022 | 6.27 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 579 | ALPP/MSLN ratio | PRORT000083 | 6.26 | Protein ratios | Renal epithelium | 35 | 1 | 5 | 10 | |
| 580 | EDAR levels | PROLV000674 | 6.25 | Protein levels | Hematopoietic progenitor | 11 | 2 | 4 | 9 | |
| 581 | Upper respiratory inflammation | RESPI000041 | 6.24 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 582 | INSR levels | PROLV001094 | 6.23 | Protein levels | Lymphocyte | 42 | 1 | 7 | 30 | |
| 583 | Hospital discharge | MISCL000023 | 6.21 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 584 | EHMT2 levels | PROLV000691 | 6.21 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 585 | Lactose intolerance | METBL000003 | 6.20 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 586 | Cholesterol, VLDL | LIPID000009 | 6.20 | Lipids | Hepatocyte | 1,391 | 2 | 9 | 14 | |
| 587 | CYB5R2 levels | PROLV000588 | 6.19 | Protein levels | Myeloid | 6 | 1 | 4 | 8 | |
| 588 | Viral wart | IMMUN000079 | 6.19 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 589 | MYOM2 levels | PROLV001364 | 6.15 | Protein levels | Muscle / cardiac | 0 | 3 | 5 | 9 | |
| 590 | Arrhythmia | CARDI000018 | 6.15 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 591 | ANGPTL3 levels | PROLV000097 | 6.15 | Protein levels | Hepatocyte | 67 | 1 | 10 | 15 | |
| 592 | TMPRSS5 levels | PROLV002050 | 6.15 | Protein levels | Neural / glial | 55 | 3 | 7 | 17 | |
| 593 | DKK1/VEGFA ratio | PRORT000904 | 6.14 | Protein ratios | Hematopoietic progenitor | 10 | 3 | 3 | 10 | |
| 594 | Blood pressure, BP, systolic | VASCU000011 | 6.13 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 595 | NCAN levels | PROLV001379 | 6.12 | Protein levels | Myeloid | 72 | 3 | 4 | 12 | |
| 596 | DNPH1/NSFL1C ratio | PRORT000935 | 6.12 | Protein ratios | Lymphocyte | 0 | 1 | 4 | 10 | |
| 597 | Viral haemorrhagic fever | IMMUN000075 | 6.11 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 598 | CNTN5 levels | PROLV000479 | 6.10 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 599 | LBR/PSRC1 ratio | PRORT001440 | 6.10 | Protein ratios | Myeloid | 1 | 4 | 10 | 15 | |
| 600 | BACH1/SNAP23 ratio | PRORT000198 | 6.09 | Protein ratios | Myeloid | 0 | 3 | 15 | 19 | |
| 601 | CXCL3/MGLL ratio | PRORT000826 | 6.08 | Protein ratios | Platelet | 0 | 2 | 5 | 16 | |
| 602 | C2 levels | PROLV000230 | 6.07 | Protein levels | B / plasma cell | 63 | 2 | 10 | 16 | |
| 603 | PDCD6IP levels | PROLV001519 | 6.07 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 604 | Depressive symptoms | PSYCH000026 | 6.07 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 605 | Body fat percentage, hormone-adjusted | BCOMP000001 | 6.06 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 606 | ACE2/MME ratio | PRORT000012 | 6.03 | Protein ratios | Hepatocyte | 40 | 1 | 5 | 9 | |
| 607 | PILRA levels | PROLV001560 | 6.03 | Protein levels | Myeloid | 54 | 1 | 9 | 10 | |
| 608 | CD40LG/SERPINE1 ratio | PRORT000453 | 6.02 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 609 | Macular puckering of retina | OPHTH000037 | 6.01 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 610 | POF1B levels | PROLV001597 | 6.00 | Protein levels | Myeloid | 7 | 3 | 17 | 20 | |
| 611 | B3GNT7 levels | PROLV000170 | 5.99 | Protein levels | Muscle / cardiac | 72 | 2 | 13 | 24 | |
| 612 | FOXO3/SH2B3 ratio | PRORT001179 | 5.99 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 613 | CA3 levels | PROLV000244 | 5.96 | Protein levels | Muscle / cardiac | 7 | 3 | 8 | 23 | |
| 614 | Immune cell marker, B cell | HEMAT000021 | 5.95 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 615 | EBAG9/TBCB ratio | PRORT000961 | 5.95 | Protein ratios | Myeloid | 0 | 2 | 7 | 16 | |
| 616 | CD109 levels | PROLV000309 | 5.94 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 617 | Brain ventricle volume | NIMAG000016 | 5.92 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 618 | Coronary artery disease, CAD | VASCU000020 | 5.91 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 619 | Trauma exposure | PSYCH000054 | 5.90 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 620 | BMP4 levels | PROLV000203 | 5.88 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 621 | Dietary pattern | DTSUP000007 | 5.87 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 622 | PAPL levels | PROLV001494 | 5.87 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 623 | Syncope | NEURO000025 | 5.84 | Neurologic | B / plasma cell | 0 | 1 | 6 | 10 | |
| 624 | TINAGL1 levels | PROLV002041 | 5.82 | Protein levels | Vascular | 55 | 4 | 8 | 15 | |
| 625 | Pregnancy complication, preterm labour | REPRO000034 | 5.82 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 626 | Triglycerides, VLDL | LIPID000036 | 5.82 | Lipids | Hepatocyte | 1,580 | 3 | 8 | 16 | |
| 627 | PSAPL1 levels | PROLV001654 | 5.81 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 628 | VNN2 levels | PROLV002165 | 5.81 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 629 | Radiotherapy | MALIG000049 | 5.80 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 630 | ADH4/KRT18 ratio | PRORT000040 | 5.78 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 631 | Brain neuroimaging quality metric | NIMAG000006 | 5.77 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 632 | LRTM2 levels | PROLV001237 | 5.74 | Protein levels | Hepatocyte | 35 | 3 | 10 | 20 | |
| 633 | CDKN1A/PLA2G4A ratio | PRORT000571 | 5.74 | Protein ratios | Vascular | 14 | 4 | 12 | 23 | |
| 634 | Pain, joint | MSKEL000036 | 5.73 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 635 | Childhood maltreatment | PSYCH000052 | 5.71 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 636 | ICAM5 levels | PROLV001008 | 5.70 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 637 | VWF levels | PROLV002182 | 5.70 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 638 | ENO2 levels | PROLV000706 | 5.69 | Protein levels | Lymphocyte | 3 | 2 | 5 | 17 | |
| 639 | KRT8 levels | PROLV001168 | 5.69 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 640 | Ovarian dysfunction | REPRO000023 | 5.68 | Reproductive | Granulosa cell | 1 | 4 | 9 | 21 | |
| 641 | CD84 levels | PROLV000359 | 5.67 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 642 | GPA33 levels | PROLV000918 | 5.66 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 643 | GLRX2 levels | PROLV000897 | 5.66 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 644 | PRND levels | PROLV001636 | 5.65 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 645 | Lipid unsaturation | LIPID000079 | 5.64 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 646 | ROBO1 levels | PROLV001749 | 5.64 | Protein levels | Myeloid | 129 | 2 | 7 | 15 | |
| 647 | GLB1 levels | PROLV000894 | 5.64 | Protein levels | Hepatocyte | 103 | 4 | 10 | 19 | |
| 648 | BCHE levels | PROLV000184 | 5.62 | Protein levels | Hepatocyte | 114 | 1 | 5 | 11 | |
| 649 | Cholesteryl esters, VLDL | LIPID000018 | 5.60 | Lipids | Hepatocyte | 1,427 | 2 | 8 | 17 | |
| 650 | FAM171B levels | PROLV000761 | 5.58 | Protein levels | Muscle / cardiac | 12 | 2 | 4 | 8 | |
| 651 | Glutathione metabolites | METAB000006 | 5.56 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 652 | Body size, childhood | BMORP000004 | 5.56 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 653 | HNRNPK/VASH1 ratio | PRORT001294 | 5.56 | Protein ratios | Myeloid | 1 | 1 | 6 | 9 | |
| 654 | ARTN levels | PROLV000148 | 5.55 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 655 | Cardiac strain rate | CARDI000006 | 5.54 | Cardiac | Muscle / cardiac | 0 | 2 | 3 | 5 | |
| 656 | ADGRG2/NRCAM ratio | PRORT000036 | 5.53 | Protein ratios | Epithelial | 20 | 3 | 10 | 12 | |
| 657 | Medication, antispasmodic | GASTR000015 | 5.52 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 658 | LY6G6C levels | PROLV001247 | 5.52 | Protein levels | Hepatocyte | 1 | 4 | 8 | 14 | |
| 659 | Fasciitis | MSKEL000063 | 5.51 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 660 | RHOC/TBCB ratio | PRORT001740 | 5.51 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 661 | Open wound | DERMA000043 | 5.50 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 662 | Cataract | OPHTH000012 | 5.50 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 663 | PILRB levels | PROLV001561 | 5.49 | Protein levels | Myeloid | 43 | 2 | 6 | 10 | |
| 664 | Rotator cuff disorder | MSKEL000066 | 5.48 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 665 | Oral health conditions, none | DENTA000009 | 5.47 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 666 | EFNA1/PIK3IP1 ratio | PRORT000989 | 5.44 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 667 | SEZ6 levels | PROLV001840 | 5.42 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 668 | LIPF levels | PROLV001216 | 5.42 | Protein levels | Epithelial | 5 | 0 | 1 | 2 | |
| 669 | ADGRG1 levels | PROLV000046 | 5.41 | Protein levels | Vascular | 22 | 3 | 11 | 26 | |
| 670 | Heart rate response to exercise | CARDI000025 | 5.40 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 671 | KAZALD1 levels | PROLV001128 | 5.40 | Protein levels | Myeloid | 79 | 2 | 8 | 18 | |
| 672 | Knee morphology | MSKEL000024 | 5.38 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 673 | Haemorrhoidal disease | VASCU000062 | 5.38 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 674 | CD163/IL18BP ratio | PRORT000382 | 5.37 | Protein ratios | Myeloid | 12 | 2 | 11 | 20 | |
| 675 | FOLR1 levels | PROLV000822 | 5.36 | Protein levels | Renal epithelium | 21 | 0 | 6 | 4 | |
| 676 | SLITRK1 levels | PROLV001888 | 5.35 | Protein levels | Myeloid | 39 | 1 | 8 | 10 | |
| 677 | MATN2/SCARA5 ratio | PRORT001494 | 5.35 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 678 | Fracture | MSKEL000011 | 5.34 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 679 | Fatty acids, total | LIPID000029 | 5.33 | Lipids | Hepatocyte | 719 | 2 | 8 | 13 | |
| 680 | Auditory performance | AUDIO000009 | 5.32 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 681 | CALCA levels | PROLV000255 | 5.32 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 682 | Metabolic syndrome | METBL000015 | 5.29 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 683 | Physical activity | BEHAV000007 | 5.29 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 684 | IDI2 levels | PROLV001010 | 5.29 | Protein levels | Muscle / cardiac | 11 | 3 | 8 | 20 | |
| 685 | Fatty acids, omega-6 | LIPID000025 | 5.28 | Lipids | Hepatocyte | 1,066 | 1 | 7 | 10 | |
| 686 | PROS1 levels | PROLV001640 | 5.27 | Protein levels | Hepatocyte | 37 | 1 | 6 | 9 | |
| 687 | COL6A3/HSPG2 ratio | PRORT000697 | 5.27 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 688 | Ataxia | NEURO000013 | 5.26 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 689 | IL18BP/THBD ratio | PRORT001347 | 5.25 | Protein ratios | Myeloid | 10 | 1 | 7 | 7 | |
| 690 | PPCDC/RWDD1 ratio | PRORT001699 | 5.24 | Protein ratios | Myeloid | 9 | 4 | 8 | 20 | |
| 691 | F12 levels | PROLV000743 | 5.24 | Protein levels | Myeloid | 72 | 2 | 6 | 11 | |
| 692 | Ventricular mass-to-volume ratio | CARDI000013 | 5.24 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 693 | Birth weight availability | MISCL000005 | 5.23 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 694 | Total lipids, IDL | LIPID000075 | 5.23 | Lipids | Hepatocyte | 281 | 1 | 7 | 12 | |
| 695 | Cancer, Brain | MALIG000010 | 5.23 | Malignancy | Muscle / cardiac | 0 | 2 | 4 | 13 | |
| 696 | Fatty acids, linoleic acid | LIPID000022 | 5.22 | Lipids | Hepatocyte | 920 | 2 | 7 | 11 | |
| 697 | IL16 levels | PROLV001050 | 5.22 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 698 | EXTL1 levels | PROLV000738 | 5.21 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 699 | Hernia | GASTR000008 | 5.20 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 700 | VNN1 levels | PROLV002164 | 5.19 | Protein levels | Hepatocyte | 55 | 3 | 12 | 25 | |
| 701 | Alpha-1-antitrypsin deficiency | RESPI000005 | 5.17 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 702 | CTBS levels | PROLV000554 | 5.16 | Protein levels | Stromal / connective | 57 | 3 | 10 | 20 | |
| 703 | SIRPA levels | PROLV001867 | 5.15 | Protein levels | Granulosa cell | 24 | 2 | 9 | 10 | |
| 704 | Fatty liver disease, nonalcoholic | HPBIL000031 | 5.15 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 705 | Hyperlipidaemia | METBL000022 | 5.15 | Metabolic | Hepatocyte | 381 | 1 | 7 | 7 | |
| 706 | SLC39A5 levels | PROLV001881 | 5.13 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 707 | Irritable bowel syndrome | GASTR000004 | 5.13 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 708 | Subcortical volume | NIMAG000026 | 5.13 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 709 | Cholesterol, LDL free | LIPID000006 | 5.12 | Lipids | Hepatocyte | 1,130 | 1 | 8 | 11 | |
| 710 | ANGPTL3/TFPI ratio | PRORT000099 | 5.12 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 711 | BAG6/WASF1 ratio | PRORT000202 | 5.11 | Protein ratios | Hepatocyte | 7 | 3 | 11 | 28 | |
| 712 | LRRC37A2 levels | PROLV001233 | 5.09 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 713 | BTD levels | PROLV000218 | 5.09 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 714 | HAVCR2/TREM2 ratio | PRORT001266 | 5.08 | Protein ratios | Myeloid | 52 | 3 | 8 | 13 | |
| 715 | AXL/MCAM ratio | PRORT000181 | 5.07 | Protein ratios | Myeloid | 18 | 2 | 5 | 15 | |
| 716 | CPXM1/SPARC ratio | PRORT000736 | 5.07 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 717 | Bone fragility disorder | MSKEL000007 | 5.07 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 718 | Perivascular space burden | NIMAG000011 | 5.06 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 719 | YBX1 levels | PROLV002204 | 5.05 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 25 | |
| 720 | Educational attainment, none | SOCIO000001 | 5.04 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 721 | Cholesterol, non-HDL | LIPID000012 | 5.04 | Lipids | Hepatocyte | 340 | 1 | 7 | 8 | |
| 722 | Cholesterol, remnant | LIPID000013 | 5.04 | Lipids | Hepatocyte | 224 | 1 | 9 | 14 | |
| 723 | Consultant specialty, ophthalmology | MISCL000018 | 5.03 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 724 | CHL1 levels | PROLV000430 | 5.03 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 725 | Gut microbial abundance, Provencibacterium | GASTR000032 | 5.02 | Gastrointestinal | Cutaneous epithelium | 0 | 1 | 12 | 9 | |
| 726 | Blood pressure, BP, arterial | VASCU000007 | 5.00 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 727 | Retinal thickness | OPHTH000043 | 5.00 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 728 | SIL1 levels | PROLV001866 | 5.00 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 729 | Medication, anti-diabetic | METBL000024 | 4.98 | Metabolic | Hematopoietic progenitor | 156 | 1 | 3 | 7 | |
| 730 | Iris and ciliary body disorder | OPHTH000005 | 4.95 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 731 | ITGBL1 levels | PROLV001117 | 4.95 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 732 | Triglycerides | LIPID000039 | 4.95 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 733 | Haemoglobin status | HEMAT000009 | 4.95 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 734 | Arthropathy | MSKEL000013 | 4.93 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 735 | Diabetes, secondary | METBL000032 | 4.93 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 736 | SLAMF8 levels | PROLV001877 | 4.92 | Protein levels | Myeloid | 34 | 5 | 12 | 28 | |
| 737 | CD69/CHMP1A ratio | PRORT000489 | 4.92 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 5 | 13 | |
| 738 | CSPG4 levels | PROLV000546 | 4.92 | Protein levels | Myeloid | 93 | 3 | 12 | 18 | |
| 739 | AMY2A levels | PROLV000090 | 4.92 | Protein levels | Epithelial | 63 | 1 | 6 | 10 | |
| 740 | MYOC/NOTCH3 ratio | PRORT001566 | 4.91 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 741 | Heart rate variability | CARDI000022 | 4.89 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 742 | TTR levels | PROLV002120 | 4.87 | Protein levels | Hepatocyte | 83 | 2 | 9 | 13 | |
| 743 | CPA1/CTRB1 ratio | PRORT000719 | 4.87 | Protein ratios | Pancreatic epithelium | 13 | 0 | 2 | 7 | |
| 744 | Arterial disease | VASCU000023 | 4.87 | Vascular | Vascular | 66 | 3 | 10 | 16 | |
| 745 | Corneal disorder | OPHTH000003 | 4.86 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 746 | CD84/GP1BA ratio | PRORT000524 | 4.86 | Protein ratios | Vascular | 17 | 2 | 10 | 19 | |
| 747 | Goitre | ENDOC000019 | 4.86 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 748 | Osteopathy | MSKEL000008 | 4.85 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 4 | 18 | |
| 749 | ADGRE2/CD58 ratio | PRORT000028 | 4.82 | Protein ratios | Myeloid | 43 | 3 | 11 | 17 | |
| 750 | PMVK/RHOC ratio | PRORT001694 | 4.82 | Protein ratios | Vascular | 0 | 2 | 9 | 10 | |
| 751 | MMP3 levels | PROLV001325 | 4.81 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 752 | JAM2/THBD ratio | PRORT001398 | 4.80 | Protein ratios | Vascular | 26 | 1 | 5 | 14 | |
| 753 | CPA1/PLA2G1B ratio | PRORT000721 | 4.79 | Protein ratios | Pancreatic epithelium | 44 | 0 | 2 | 5 | |
| 754 | Myo-inositol | METAB000036 | 4.78 | Metabolites | Lymphocyte | 0 | 1 | 10 | 27 | |
| 755 | ANGPTL7 levels | PROLV000099 | 4.76 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 756 | CHMP1A levels | PROLV000431 | 4.75 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 757 | GGT5 levels | PROLV000884 | 4.74 | Protein levels | Hepatocyte | 21 | 1 | 8 | 12 | |
| 758 | CCDC80/CHRDL1 ratio | PRORT000333 | 4.72 | Protein ratios | Vascular | 10 | 1 | 5 | 15 | |
| 759 | Neurodegenerative disorder | NEURO000021 | 4.72 | Neurologic | Myeloid | 59 | 2 | 12 | 9 | |
| 760 | Urinary system disorder | NEPHR000005 | 4.70 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 761 | ART3/RGMB ratio | PRORT000146 | 4.69 | Protein ratios | Myeloid | 11 | 3 | 8 | 23 | |
| 762 | CD99/MMP3 ratio | PRORT000535 | 4.68 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 763 | Brain functional activity | NIMAG000001 | 4.68 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 764 | SFTPD levels | PROLV001849 | 4.68 | Protein levels | Vascular | 77 | 1 | 5 | 14 | |
| 765 | Premature cardiac beat | CARDI000023 | 4.67 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 766 | Phospholipids, VLDL | LIPID000051 | 4.66 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 767 | ACHE levels | PROLV000012 | 4.64 | Protein levels | Hepatocyte | 125 | 2 | 8 | 15 | |
| 768 | Hypothyroidism, congenital iodine deficiency | ENDOC000013 | 4.64 | Endocrine | Muscle / cardiac | 0 | 1 | 5 | 11 | |
| 769 | NAAA levels | PROLV001369 | 4.64 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 770 | Miscarriage | REPRO000038 | 4.63 | Reproductive | Lymphocyte | 0 | 2 | 15 | 31 | |
| 771 | Heme malignancy, Plasma cell | MALIG000046 | 4.63 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 772 | CXCL3 levels | PROLV000583 | 4.62 | Protein levels | Stromal / connective | 18 | 2 | 5 | 5 | |
| 773 | HSBP1 levels | PROLV000992 | 4.60 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 774 | Weight change | BMORP000016 | 4.60 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 775 | Dorsopathy | MSKEL000075 | 4.59 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 776 | ICA1/YTHDF3 ratio | PRORT001321 | 4.58 | Protein ratios | Neural / glial | 16 | 1 | 5 | 12 | |
| 777 | WASL levels | PROLV002187 | 4.57 | Protein levels | B / plasma cell | 54 | 2 | 8 | 16 | |
| 778 | LCN2/PGLYRP1 ratio | PRORT001441 | 4.55 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 779 | EPCAM/GPA33 ratio | PRORT001035 | 4.54 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 780 | Wellbeing | PSYCH000056 | 4.54 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 781 | PTPN1/TDRKH ratio | PRORT001717 | 4.53 | Protein ratios | Granulosa cell | 1 | 2 | 5 | 7 | |
| 782 | ASGR1 levels | PROLV000151 | 4.52 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 783 | CDCP1 levels | PROLV000370 | 4.52 | Protein levels | Myeloid | 85 | 3 | 9 | 16 | |
| 784 | ITIH3/VCAM1 ratio | PRORT001395 | 4.51 | Protein ratios | Hepatocyte | 37 | 3 | 11 | 20 | |
| 785 | PON2/PON3 ratio | PRORT001698 | 4.50 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 786 | Peripheral artery disease | VASCU000042 | 4.50 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 787 | PDCD1/TNFRSF9 ratio | PRORT001631 | 4.50 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 788 | Cancer, Oesophagus | MALIG000021 | 4.49 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 789 | MAP2K6/MGMT ratio | PRORT001485 | 4.49 | Protein ratios | Epithelial | 0 | 0 | 11 | 12 | |
| 790 | Frailty, general | MISCL000039 | 4.49 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 791 | CGREF1 levels | PROLV000421 | 4.49 | Protein levels | Hepatocyte | 11 | 0 | 6 | 9 | |
| 792 | Memory disorder | PSYCH000006 | 4.49 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 793 | SERPINF1 levels | PROLV001832 | 4.48 | Protein levels | Vascular | 7 | 0 | 6 | 8 | |
| 794 | APOE levels | PROLV000124 | 4.48 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 795 | Consultant specialty, general surgery | MISCL000017 | 4.48 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 796 | Consultant specialty, urology | MISCL000020 | 4.47 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 797 | LTA/LTBR ratio | PRORT001463 | 4.47 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 798 | F7 levels | PROLV000748 | 4.46 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 799 | ESAM/LAMA4 ratio | PRORT001063 | 4.46 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 800 | C1QTNF1 levels | PROLV000224 | 4.45 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 801 | FLT3/FLT3LG ratio | PRORT001165 | 4.42 | Protein ratios | Lymphocyte | 5 | 5 | 11 | 30 | |
| 802 | Neoplasm, uncertain behaviour | MALIG000035 | 4.42 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 803 | PGLS levels | PROLV001545 | 4.42 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 804 | Intracranial volume | NIMAG000025 | 4.41 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 805 | CD5/IL16 ratio | PRORT000467 | 4.41 | Protein ratios | Myeloid | 36 | 4 | 16 | 40 | |
| 806 | CTSZ/NAAA ratio | PRORT000805 | 4.41 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 807 | BCL2L11/RAB6A ratio | PRORT000220 | 4.40 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 8 | |
| 808 | AXL levels | PROLV000167 | 4.37 | Protein levels | Myeloid | 83 | 4 | 14 | 44 | |
| 809 | Cardiac procedure, angioplasty | VASCU000057 | 4.37 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 810 | Family history, hypertension | VASCU000022 | 4.35 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 811 | Corneal properties | OPHTH000010 | 4.35 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 812 | Household composition | SOCIO000010 | 4.35 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 813 | IL7R levels | PROLV001081 | 4.35 | Protein levels | Hepatocyte | 78 | 3 | 10 | 27 | |
| 814 | Transport mode | BEHAV000009 | 4.33 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 815 | Diverticular disease | GASTR000011 | 4.33 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 816 | CLEC1A levels | PROLV000447 | 4.32 | Protein levels | Myeloid | 10 | 0 | 5 | 9 | |
| 817 | EFEMP1 levels | PROLV000679 | 4.31 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 818 | RAB6A levels | PROLV001700 | 4.31 | Protein levels | Hepatocyte | 83 | 2 | 7 | 20 | |
| 819 | LGALS8/SOD2 ratio | PRORT001453 | 4.31 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 820 | Study participation | BEHAV000004 | 4.30 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 821 | HLA-DRA levels | PROLV000975 | 4.30 | Protein levels | Myeloid | 117 | 3 | 8 | 14 | |
| 822 | Consultant specialty, cardiology | CARDI000037 | 4.30 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 823 | FUT3 or FUT5 levels | PROLV000838 | 4.30 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 824 | HBB levels | PROLV000955 | 4.30 | Protein levels | Hepatocyte | 847 | 1 | 9 | 7 | |
| 825 | S100A16 levels | PROLV001770 | 4.29 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 826 | Cholesterol, free | LIPID000011 | 4.29 | Lipids | Hepatocyte | 300 | 1 | 6 | 17 | |
| 827 | Iron | METAB000046 | 4.26 | Metabolites | Muscle / cardiac | 0 | 1 | 7 | 14 | |
| 828 | NTRK2 levels | PROLV001447 | 4.25 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 829 | Cholesterol, IDL free | LIPID000004 | 4.24 | Lipids | Hepatocyte | 608 | 1 | 9 | 12 | |
| 830 | Nephrotic syndrome | NEPHR000011 | 4.24 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 831 | BCAN/CD200 ratio | PRORT000214 | 4.23 | Protein ratios | Granulosa cell | 11 | 2 | 7 | 8 | |
| 832 | LEP levels | PROLV001199 | 4.22 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 833 | Medication, anti-gout | METBL000025 | 4.22 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 834 | Hippocampal volume | NIMAG000024 | 4.21 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 835 | Hypertension, secondary | VASCU000026 | 4.21 | Vascular | Renal epithelium | — | 0 | 17 | 26 | |
| 836 | Polycystic ovary syndrome | REPRO000024 | 4.20 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 837 | CTF1/ITGB1BP2 ratio | PRORT000793 | 4.20 | Protein ratios | Hematopoietic progenitor | 18 | 4 | 10 | 21 | |
| 838 | Dietary change, none | DTSUP000005 | 4.19 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 839 | CTSH levels | PROLV000565 | 4.19 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 840 | CA1/CA3 ratio | PRORT000268 | 4.19 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 841 | FOLR2/THY1 ratio | PRORT001170 | 4.19 | Protein ratios | Myeloid | 53 | 4 | 13 | 19 | |
| 842 | Upper gastrointestinal disorder | GASTR000054 | 4.18 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 843 | ANXA3/ENO2 ratio | PRORT000106 | 4.18 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 6 | 13 | |
| 844 | Hip joint morphology | MSKEL000023 | 4.17 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 845 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 4.17 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 846 | Lipoprotein particles, LDL | LIPID000045 | 4.17 | Lipids | Hepatocyte | 493 | 1 | 8 | 11 | |
| 847 | EFEMP1/FSTL3 ratio | PRORT000986 | 4.14 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 848 | Lipoprotein particles, IDL | LIPID000044 | 4.13 | Lipids | Hepatocyte | 254 | 1 | 6 | 14 | |
| 849 | Operation, gastrointestinal | GASTR000039 | 4.13 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 850 | Dentures | DENTA000006 | 4.13 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 851 | Functional gastrointestinal disorder | GASTR000003 | 4.13 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 852 | PEPD levels | PROLV001536 | 4.12 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 853 | MEGF9/OXT ratio | PRORT001514 | 4.12 | Protein ratios | Hepatocyte | 34 | 1 | 4 | 15 | |
| 854 | BRK1 levels | PROLV000213 | 4.11 | Protein levels | Vascular | 25 | 3 | 9 | 17 | |
| 855 | CD93 levels | PROLV000362 | 4.08 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 856 | FYN levels | PROLV000843 | 4.07 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 857 | Metabolic disorder | METBL000014 | 4.05 | Metabolic | Hepatocyte | 114 | 1 | 7 | 15 | |
| 858 | Dihydrosphingomyelins | LIPID000067 | 4.05 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 859 | Phospholipid species | LIPID000064 | 4.04 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 860 | Estradiol | ENDOC000006 | 4.03 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 861 | ADGRE5/NOTCH1 ratio | PRORT000032 | 4.02 | Protein ratios | Myeloid | 54 | 3 | 13 | 15 | |
| 862 | AGRP/NPY ratio | PRORT000050 | 4.01 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 863 | EGFR/FAP ratio | PRORT001000 | 4.00 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 864 | TREM2 levels | PROLV002102 | 4.00 | Protein levels | Myeloid | 120 | 3 | 7 | 12 | |
| 865 | IL22 levels | PROLV001066 | 4.00 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 866 | Organic acid metabolites | METAB000067 | 4.00 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 867 | GLB1/IMPA1 ratio | PRORT001216 | 3.99 | Protein ratios | Myeloid | 65 | 4 | 11 | 19 | |
| 868 | Brain structural connectivity | NIMAG000007 | 3.97 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 869 | SLC9A3R2 levels | PROLV001886 | 3.97 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 870 | FGF19/SCG2 ratio | PRORT001139 | 3.97 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 871 | SPTLC1 levels | PROLV001941 | 3.97 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 872 | SERPINB9 levels | PROLV001827 | 3.96 | Protein levels | Stromal / connective | 14 | 3 | 3 | 10 | |
| 873 | Total lipids, LDL | LIPID000076 | 3.96 | Lipids | Hepatocyte | 379 | 1 | 7 | 9 | |
| 874 | Alcohol preference | PSYCH000042 | 3.94 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 875 | RBP7 levels | PROLV001713 | 3.94 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 876 | Temporomandibular joint disorder | MSKEL000022 | 3.92 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 877 | CREG1 levels | PROLV000517 | 3.92 | Protein levels | Hepatocyte | 128 | 2 | 13 | 21 | |
| 878 | MEGF10 levels | PROLV001293 | 3.92 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 879 | ITPR1 levels | PROLV001122 | 3.92 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 880 | ANCA-associated vasculitis | IMMUN000021 | 3.91 | Immunologic | Adipose | 2 | 0 | 1 | 4 | |
| 881 | PPP1R2/TBL1X ratio | PRORT001706 | 3.91 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 882 | Lactate | METAB000066 | 3.89 | Metabolites | Myeloid | 0 | 1 | 5 | 10 | |
| 883 | Intestinal disorder | GASTR000012 | 3.89 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 884 | Ischaemic stroke | VASCU000015 | 3.88 | Vascular | Muscle / cardiac | 4 | 3 | 8 | 13 | |
| 885 | Grain and bakery preference | DTSUP000013 | 3.88 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 886 | CPB2 levels | PROLV000505 | 3.87 | Protein levels | Myeloid | 66 | 3 | 9 | 16 | |
| 887 | Foot surgery | MSKEL000046 | 3.87 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 888 | Gut microbial pathway abundance | GASTR000038 | 3.87 | Gastrointestinal | Hepatocyte | 0 | 3 | 9 | 26 | |
| 889 | AXL/CD163 ratio | PRORT000178 | 3.87 | Protein ratios | Myeloid | 19 | 4 | 18 | 33 | |
| 890 | MMP8/PGLYRP1 ratio | PRORT001544 | 3.86 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 891 | ADAM15 levels | PROLV000026 | 3.85 | Protein levels | Lymphocyte | 72 | 2 | 16 | 38 | |
| 892 | CD69/TXNDC5 ratio | PRORT000501 | 3.84 | Protein ratios | Vascular | 1 | 2 | 10 | 13 | |
| 893 | UFC1 levels | PROLV002136 | 3.84 | Protein levels | Myeloid | 1 | 4 | 7 | 14 | |
| 894 | Osteochondrodysplasia | MSKEL000054 | 3.84 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 895 | Cholesterol, LDL | LIPID000007 | 3.83 | Lipids | Hepatocyte | 1,987 | 1 | 6 | 12 | |
| 896 | Medication, sleep apnoea | RESPI000008 | 3.83 | Respiratory | Cutaneous epithelium | 0 | 1 | 8 | 15 | |
| 897 | ERBB3 levels | PROLV000725 | 3.83 | Protein levels | Hepatocyte | 97 | 4 | 10 | 20 | |
| 898 | RRM2B/SMAD1 ratio | PRORT001749 | 3.82 | Protein ratios | Hepatocyte | 1 | 1 | 5 | 18 | |
| 899 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 3.82 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 900 | VGF levels | PROLV002161 | 3.81 | Protein levels | Hepatocyte | 30 | 1 | 5 | 9 | |
| 901 | ALPP/LAMP3 ratio | PRORT000082 | 3.81 | Protein ratios | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 902 | Kidney cyst | NEPHR000004 | 3.81 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 903 | CEACAM19 levels | PROLV000389 | 3.80 | Protein levels | Cutaneous epithelium | 26 | 1 | 9 | 8 | |
| 904 | ICAM4 levels | PROLV001007 | 3.80 | Protein levels | Lymphocyte | 53 | 2 | 13 | 33 | |
| 905 | MMP7 levels | PROLV001326 | 3.80 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 906 | FAP levels | PROLV000769 | 3.80 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 907 | Falling risk | MISCL000040 | 3.78 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 908 | Hip index | BMORP000012 | 3.77 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 909 | MMP13 levels | PROLV001324 | 3.76 | Protein levels | Stromal / connective | 0 | 1 | 4 | 5 | |
| 910 | AXL/VCAM1 ratio | PRORT000183 | 3.76 | Protein ratios | Myeloid | 85 | 4 | 15 | 37 | |
| 911 | CPA2/ITGB7 ratio | PRORT000723 | 3.76 | Protein ratios | Hepatocyte | 53 | 1 | 11 | 16 | |
| 912 | APCS levels | PROLV000113 | 3.76 | Protein levels | Myeloid | 68 | 3 | 12 | 20 | |
| 913 | CCL25 levels | PROLV000292 | 3.75 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 914 | CEACAM16 levels | PROLV000388 | 3.75 | Protein levels | Hepatocyte | 128 | 1 | 7 | 11 | |
| 915 | Smoking dependency | PSYCH000047 | 3.72 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 916 | Beverage preference | DTSUP000001 | 3.72 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 917 | HSPG2/SMOC2 ratio | PRORT001309 | 3.71 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 918 | Eustachian tube disorder | AUDIO000015 | 3.71 | Auditory | Epithelial | 0 | 0 | 6 | 8 | |
| 919 | PPP1R12A/TXNDC5 ratio | PRORT001703 | 3.69 | Protein ratios | Hepatocyte | 10 | 3 | 10 | 31 | |
| 920 | Trigger finger | MSKEL000072 | 3.69 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 921 | CD163/FOLR2 ratio | PRORT000380 | 3.69 | Protein ratios | Myeloid | 56 | 4 | 12 | 18 | |
| 922 | ICA1/MVK ratio | PRORT001319 | 3.69 | Protein ratios | Hepatocyte | 5 | 1 | 7 | 7 | |
| 923 | TRAF3 levels | PROLV002100 | 3.68 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 924 | ASPN levels | PROLV000153 | 3.68 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 925 | AGXT/MME ratio | PRORT000053 | 3.68 | Protein ratios | Hepatocyte | 47 | 1 | 4 | 11 | |
| 926 | HRC levels | PROLV000987 | 3.65 | Protein levels | Stromal / connective | 43 | 5 | 12 | 32 | |
| 927 | White matter volume | NIMAG000028 | 3.64 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 928 | Heme malignancy, Lymphoma | MALIG000044 | 3.64 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 929 | Myocardial infarction | CARDI000042 | 3.63 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 930 | Vegetable preference | DTSUP000020 | 3.63 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 931 | IPCEF1/TBCB ratio | PRORT001364 | 3.62 | Protein ratios | Stromal / connective | 2 | 3 | 5 | 5 | |
| 932 | Testosterone | ENDOC000010 | 3.62 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 933 | BTN2A1/LILRB4 ratio | PRORT000258 | 3.61 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 934 | VSNL1 levels | PROLV002173 | 3.60 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 935 | ADGRE5 levels | PROLV000044 | 3.60 | Protein levels | Myeloid | 168 | 3 | 7 | 14 | |
| 936 | FGL1 levels | PROLV000803 | 3.59 | Protein levels | Hepatocyte | 58 | 3 | 12 | 23 | |
| 937 | EREG/MPIG6B ratio | PRORT001058 | 3.59 | Protein ratios | Myeloid | 15 | 3 | 10 | 15 | |
| 938 | CCN5 levels | PROLV000305 | 3.59 | Protein levels | Vascular | 15 | 0 | 5 | 12 | |
| 939 | CD4/LILRB4 ratio | PRORT000441 | 3.59 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 940 | ITGB1BP2/MITD1 ratio | PRORT001385 | 3.59 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 941 | KCNA10 levels | PROLV001130 | 3.59 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 942 | CNPY4/ERBIN ratio | PRORT000679 | 3.58 | Protein ratios | Hepatocyte | 19 | 4 | 7 | 19 | |
| 943 | VSIG10 levels | PROLV002169 | 3.58 | Protein levels | Muscle / cardiac | 3 | 1 | 4 | 7 | |
| 944 | Cancer, Liver | MALIG000018 | 3.58 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 945 | ERN1 levels | PROLV000730 | 3.56 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 946 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 3.56 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 947 | NOS1 levels | PROLV001414 | 3.56 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 10 | |
| 948 | CD63/CLEC1B ratio | PRORT000485 | 3.54 | Protein ratios | Myeloid | 1 | 5 | 11 | 18 | |
| 949 | Family history, coronary artery disease | VASCU000021 | 3.53 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 950 | IL22RA2 levels | PROLV001067 | 3.53 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 951 | PLA2G1B/PRSS2 ratio | PRORT001672 | 3.53 | Protein ratios | Hepatocyte | 44 | 1 | 2 | 8 | |
| 952 | OXT levels | PROLV001480 | 3.53 | Protein levels | Hepatocyte | 94 | 2 | 7 | 11 | |
| 953 | Medication, ACE inhibitor | VASCU000028 | 3.52 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 954 | Medication, renin-angiotensin system agent | VASCU000040 | 3.52 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 955 | Diabetes, general | METBL000030 | 3.52 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 956 | Gut microbial abundance, Microvirga | GASTR000029 | 3.51 | Gastrointestinal | Melanocyte | 0 | 7 | 10 | 14 | |
| 957 | CTSC levels | PROLV000561 | 3.51 | Protein levels | Hepatocyte | 71 | 3 | 13 | 17 | |
| 958 | Nucleoside metabolites | METAB000061 | 3.48 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 959 | Atherosclerosis | VASCU000006 | 3.47 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 960 | Nephritis and nephropathy | NEPHR000010 | 3.47 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 961 | Dementia | NEURO000019 | 3.47 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 962 | Atrial fibrillation and flutter | CARDI000019 | 3.46 | Cardiac | Muscle / cardiac | 758 | 2 | 4 | 8 | |
| 963 | WASF1 levels | PROLV002185 | 3.46 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 964 | CPQ levels | PROLV000509 | 3.46 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 965 | Phosphatidates | LIPID000057 | 3.45 | Lipids | Melanocyte | 0 | 1 | 2 | 4 | |
| 966 | CES1 levels | PROLV000405 | 3.45 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 967 | PDCD1/TNFRSF4 ratio | PRORT001629 | 3.45 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 968 | STAB2 levels | PROLV001956 | 3.44 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 969 | NPY levels | PROLV001429 | 3.44 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 970 | Glycine | METAB000022 | 3.43 | Metabolites | Hepatocyte | 498 | 1 | 7 | 11 | |
| 971 | CSF1/LTBR ratio | PRORT000778 | 3.42 | Protein ratios | Myeloid | 29 | 5 | 13 | 24 | |
| 972 | PLG levels | PROLV001577 | 3.41 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 973 | Alanine metabolite | METAB000001 | 3.40 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 974 | COL6A3/CST3 ratio | PRORT000696 | 3.39 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 975 | Spinal deformity | MSKEL000077 | 3.39 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 976 | Lung volume | RESPI000022 | 3.38 | Respiratory | Myeloid | 4 | 3 | 7 | 12 | |
| 977 | Sleep-related movement disorder | NEURO000016 | 3.38 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 978 | Blood pressure, BP, diastolic x sex interaction | VASCU000008 | 3.36 | Vascular | Muscle / cardiac | 0 | 2 | 12 | 23 | |
| 979 | CNTN4 levels | PROLV000478 | 3.35 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 980 | HNRNPK levels | PROLV000982 | 3.34 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 981 | Cirrhosis | HPBIL000006 | 3.33 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 982 | TFF1 levels | PROLV002012 | 3.33 | Protein levels | Salivary epithelium | 15 | 1 | 2 | 7 | |
| 983 | GFRAL levels | PROLV000879 | 3.33 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 984 | APOB levels | PROLV000120 | 3.33 | Protein levels | Hepatocyte | 618 | 1 | 7 | 9 | |
| 985 | LCN2/PRTN3 ratio | PRORT001442 | 3.32 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 986 | NECTIN2 levels | PROLV001387 | 3.32 | Protein levels | Vascular | 34 | 0 | 5 | 13 | |
| 987 | BSG levels | PROLV000214 | 3.31 | Protein levels | Hepatocyte | 82 | 2 | 6 | 9 | |
| 988 | Cerebral ischaemia | VASCU000012 | 3.31 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 989 | Triglycerides, total | LIPID000037 | 3.31 | Lipids | Hepatocyte | 2,195 | 3 | 7 | 16 | |
| 990 | Gut microbial abundance, CAG-776 | GASTR000023 | 3.29 | Gastrointestinal | Neural / glial | 0 | 2 | 4 | 16 | |
| 991 | UCMA levels | PROLV002135 | 3.29 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 992 | Cholesterol, esterified | LIPID000010 | 3.28 | Lipids | Hepatocyte | 379 | 2 | 8 | 13 | |
| 993 | MUC16 levels | PROLV001352 | 3.28 | Protein levels | Vascular | 0 | 0 | 4 | 3 | |
| 994 | ENO2/PRSS27 ratio | PRORT001028 | 3.28 | Protein ratios | Myeloid | 0 | 2 | 7 | 30 | |
| 995 | Anaemia of chronic kidney disease | HEMAT000003 | 3.28 | Hematologic | Hepatocyte | 4 | 3 | 7 | 14 | |
| 996 | Colonic and urogenital fistula | GASTR000010 | 3.27 | Gastrointestinal | Lymphocyte | 1 | 1 | 3 | 18 | |
| 997 | Creatine kinase | MSKEL000027 | 3.27 | Musculoskeletal | Muscle / cardiac | 145 | 4 | 10 | 21 | |
| 998 | COL6A3/SMOC2 ratio | PRORT000700 | 3.27 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 999 | Phospholipids, lipoprotein particles | LIPID000052 | 3.26 | Lipids | Hepatocyte | 430 | 2 | 9 | 15 | |
| 1000 | MOG levels | PROLV001332 | 3.26 | Protein levels | Pancreatic epithelium | 7 | 0 | 6 | 13 |